Business
Genvor Announces Issuance of New U.S. Patent for Corn with Antifungal Peptide
Genvor Announces Issuance of New U.S. Patent for Corn with Antifungal Peptide.
About this update from Genvor Incorporated
[{"type":"text","content":"\r\n\r\n \r\n \r\n Genvor Announces Issuance of New U.S. Patent for Corn with Antifungal Peptide\r\n \r\n \r\n\r\n\r\nGenvor Announces Issuance of New U.S. Patent for Corn with Antifungal Peptide\r\n\r\n\r\n\r\n\r\n\r\nWoodland, CA, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR), a pioneer in AI-accelerated peptide technology for sustainable agriculture, announced today the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,458,684, titled “Transgenic Corn with Antifungal Peptide AGM182.” The patent, co-assigned to Genvor Inc. and the United States Department of Agriculture (USDA), covers transgenic corn expressing the antifungal peptide AGM182, designed to combat fungal infections in maize. The patent covers novel biological compositions shown to reduce the presence of Aspergillus flavus, a fungal pathogen known to produce aflatoxins, which is a naturally occurring toxic and carcinogenic compound that can contaminate corn and other crops. Research supporting the patent also demonstrated activity against additional mycotoxin-producing fungi, including those associated with Fusarium species. “This patent represents a significant milestone in Genvor’s growth as we continue to expand our intellectual property portfolio and deliver sustainable solutions for global agriculture,” said Chad Pawlak, Chief Executive Officer of Genvor. “The AGM182 technology exemplifies our BioCypher™ Algorithm’s power to design next-generation antimicrobial peptides that are highly active, versatile, and effective in foliar formulations as well as in transgenic seed applications.” Economic losses from fungal diseases in corn are substantial, with total annual U.S. losses estimated between $3 billion to $5 billion when accounting for yield reductions and quality degradation across all major pathogens. According to widely referenced economic modeling, aflatoxin contamination in U.S. corn has potential annual market impacts ranging from approximately $52 million in lower-risk years to as much as $1.68 billion in high-risk years, reflecting the variability driven by drought, heat stress, and other environmental stressors. These impacts underscore the need for new biological tools that can reduce both fungal infection and mycotoxin accumulat...